Skip to main content

Semler Scientific Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Current Price

$20.33

+0.00%

GoodMoat Value

$128.87

533.9% undervalued
Profile
Valuation (TTM)
Market Cap$300.98M
P/E6.23
EV
P/B1.30
Shares Out14.80M
P/Sales8.14
Revenue$36.96M
EV/EBITDA6.15

Semler Scientific Inc (SMLR) Quality Analysis

SMLR GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

SMLR Profitability

Profitability trend analysis coming soon

SMLR Growth

Growth trend analysis coming soon

SMLR Financial Health

Financial health indicators coming soon

SMLR Quality & Fundamental Analysis

Semler Scientific Inc (SMLR) is a Healthcare company in the Medical Devices industry, listed on NASDAQ. This quality analysis page evaluates Semler Scientific Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Semler Scientific Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 130.80% and a return on equity (ROE) of 20.95%. Return on assets (ROA) stands at 20.16%.

with a current ratio of 3.59. Operating margin is 37.19%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Semler Scientific Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.